Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita.
Defects in ribosome biogenesis and function are present in a growing list of human syndromes associated with cancer susceptibility. One example is X-linked dyskeratosis congenita (X-DC) in which the DKC1 gene, encoding for an enzyme that modifies ribosomal RNA, is found to be mutated. How ribosome dysfunction leads to cancer remains poorly understood. A critical cellular response that counteracts cellular transformation is oncogene-induced senescence (OIS). Here, we show that during OIS, a switch between cap- and internal ribosome entry site (IRES)-dependent translation occurs. During this switch, an IRES element positioned in the 5'untranslated region of p53 is engaged and facilitates p53 translation. We further show that in DKC1(m) cells, p53 IRES-dependent translation is impaired during OIS ex vivo and on DNA damage in vivo. This defect in p53 translation perturbs the cellular response that counteracts oncogenic insult. We extend these findings to X-DC human patient cells in which similar impairments in p53 IRES-dependent translation are observed. Importantly, re-introduction of wild-type DKC1 restores p53 expression in these cells. These results provide insight into the basis for cancer susceptibility in human syndromes associated with ribosome dysfunction.
Bellodi
Cristian
C
School of Medicine and Department of Urology, Helen Diller Family Comprehensive Center, University of California, San Francisco, CA, USA.
Kopmar
Noam
N
Ruggero
Davide
D
D000375:Aging / Q000235:genetics*; D004249:DNA Damage; D019871:Dyskeratosis Congenita / Q000235:genetics* / Q000378:metabolism; D016158:Genes, p53; D006801:Humans; D009857:Oncogenes; D012335:RNA, Ribosomal / Q000235:genetics / Q000378:metabolism; D012270:Ribosomes / Q000235:genetics / Q000378:metabolism*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*; D020506:Untranslated Regions
D012335:RNA, Ribosomal; D016159:Tumor Suppressor Protein p53; D020506:Untranslated Regions
Cell. 1997 Mar 7;88(5):593-602
9054499
Chromosoma. 2005 May;114(1):1-14
15770508
Sci STKE. 2004 Mar 09;2004(224):pe10
15026578
Mol Cell Biol. 2001 Jul;21(13):4246-55
11390653
Am J Hum Genet. 1999 Jul;65(1):50-8
10364516
Gene. 2007 Jun 15;395(1-2):1-7
17395405
Biochem Biophys Res Commun. 2005 Jun 10;331(3):881-90
15865944
J Clin Invest. 2009 May;119(5):1109-23
19363292
RNA. 2007 Dec;13(12):2224-37
17921318
Nat Rev Cancer. 2003 Mar;3(3):179-92
12612653
Genes Dev. 1998 Oct 1;12(19):3008-19
9765203
Br J Haematol. 2008 May;141(3):376-87
18410571
Science. 2003 Jan 10;299(5604):259-62
12522253
PLoS One. 2009;4(5):e5475
19421407
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10173-8
18626023
Nature. 2005 Aug 4;436(7051):725-30
16079851
EMBO Rep. 2006 Apr;7(4):404-10
16440000
Nature. 1998 Sep 10;395(6698):125-6
9744268
Mol Cell. 2008 Oct 24;32(2):180-9
18951086
Clin Genet. 2008 Feb;73(2):103-12
18005359
Nature. 1999 Dec 2;402(6761):551-5
10591218
Nature. 2005 Aug 4;436(7051):660-5
16079837
Nature. 2005 Aug 4;436(7051):642
16079833
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5025-30
11309506
Oncogene. 2006 Aug 3;25(33):4613-9
16607284
Blood. 2009 Jun 25;113(26):6549-57
19282459
Nat Rev Mol Cell Biol. 2005 Apr;6(4):318-27
15803138
Cell. 2005 Oct 7;123(1):49-63
16213212
EMBO J. 2006 Mar 8;25(5):1114-25
16467844
Mol Cell. 2000 Apr;5(4):607-16
10882097
Science. 2006 May 12;312(5775):902-6
16690864